Instrument Inactif

Autres langues COMBIMATR Nasdaq

Actions

Installations et services en soins de santé

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

Autres langues

10/11/17	CombiMatrix Corporation Stockholders Approve Merger Agreement With Invitae Corporation
06/11/17	CombiMatrix Corporation Reports Third Quarter 2017 Financial and Operating Results
02/11/17	CombiMatrix Corporation Reminds Shareholders to Vote "FOR" the Merger With Invitae Corporation
01/11/17	Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend CombiMatrix Corporation Shareholders Vote "FOR" the Proposed Merger with Invitae Corporation
20/10/17	CombiMatrix to Present New Data from a Large-Scale Analysis of Genomic Abnormalities Impacting Multiple Stages of Human Growth and Development Starting from Conception through Childhood at the American Society of Human Genetics Annual Meeting
25/09/17	CombiMatrix Sets Record Date and Special Stockholders Meeting Date Regarding Proposed Merger with Invitae
03/08/17	CombiMatrix Corporation Reports Second Quarter 2017 Financial and Operating Results
31/07/17	CombiMatrix Enters Into Merger Agreement with Invitae Corporation to be Acquired for $33 Million in Invitae Common Stock
22/05/17	CombiMatrix to Present at Upcoming Investor Conferences
04/05/17	CombiMatrix Corporation Reports First Quarter 2017 Financial and Operating Results
27/04/17	CombiMatrix Corporation to Release 2017 First Quarter Financial Results on May 4, 2017
01/03/17	CombiMatrix Appoints Molecular Diagnostics Veteran Dirk van den Boom, Ph.D. to its Board of Directors
22/02/17	CombiMatrix Corporation Reports 2016 Fourth Quarter and Full Year Financial and Operating Results
15/02/17	CombiMatrix Corporation to Release 2016 Fourth Quarter and Full Year Financial Results on February 22, 2017
08/02/17	CombiMatrix to Present at 2nd Annual Disruptive Growth & Healthcare Conference
02/02/17	CombiMatrix Appoints Preeminent Pediatric Neurologist Dr. James W. Wheless to its Scientific Advisory Board
20/01/17	CombiMatrix to Present Large-Scale Study Indicating the Severity of Genomic Abnormalities Decreases from Conception to Childhood at the 2nd Congress on Recurrent Pregnancy Loss
29/11/16	CombiMatrix : Pre-Implantation Genetic Screening by Next Generation Sequencing Granted Conditional Approval from New York State Department of Health
29/11/16	CombiMatrix’s Pre-Implantation Genetic Screening by Next Generation Sequencing Granted Conditional Approval from New York State Department of Health
02/11/16	CombiMatrix Corporation Reports Third Quarter 2016 Financial and Operating Results
26/10/16	CombiMatrix Corporation to Release 2016 Third Quarter Financial Results on November 2, 2016
08/09/16	CombiMatrix to Present at September Investment Conferences
16/08/16	CombiMatrix Notes Decision by Health Care Service Corporation to Reimburse for Recurrent Pregnancy Loss Testing
10/08/16	CombiMatrix Announces Distribution Agreement with Universal Diagnostic Laboratories for Miscarriage Analysis Testing
03/08/16	CombiMatrix Corporation Reports Second Quarter 2016 Financial and Operating Results